太龙药业2023年净利4355.67万同比扭亏为盈总经理李景亮薪酬117.05万

挖贝网03-27

挖贝网3月27日，太龙药业近日发布2023年年度报告，报告期内公司实现营业收入2,069,908,736.55元，同比增长5.57%；归属于上市公司股东的净利润43,556,724.78元，较上年同期扭亏为盈。报告期内经营活动产生的现金流量净额为43,737,575.40元，归属于上市公司股东的净资产1,578,493,578.60元。报告期内，随着外部环境的稳定，公司经营业务稳健增长、持续向好...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2422182159?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-03-27 21:52","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2422182159","market":"sh","top_or_hot":-1,"title":"太龙药业2023年净利4355.67万同比扭亏为盈 总经理李景亮薪酬117.05万","media":"挖贝网","content":"<div>\n<p>挖贝网3月27日，太龙药业 近日发布2023年年度报告，报告期内公司实现营业收入2,069,908,736.55元，同比增长5.57%；归属于上市公司股东的净利润43,556,724.78元，较上年同期扭亏为盈。报告期内经营活动产生的现金流量净额为43,737,575.40元，归属于上市公司股东的净资产1,578,493,578.60元。报告期内，随着外部环境的稳定，公司经营业务稳健增长、持续向好...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403272156198b69e996&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>太龙药业2023年净利4355.67万同比扭亏为盈 总经理李景亮薪酬117.05万</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n太龙药业2023年净利4355.67万同比扭亏为盈 总经理李景亮薪酬117.05万\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-27 21:52 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403272156198b69e996&s=b><strong>挖贝网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>挖贝网3月27日，太龙药业 近日发布2023年年度报告，报告期内公司实现营业收入2,069,908,736.55元，同比增长5.57%；归属于上市公司股东的净利润43,556,724.78元，较上年同期扭亏为盈。报告期内经营活动产生的现金流量净额为43,737,575.40元，归属于上市公司股东的净资产1,578,493,578.60元。报告期内，随着外部环境的稳定，公司经营业务稳健增长、持续向好...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403272156198b69e996&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403272156198b69e996&s=b","article_id":"2422182159","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403272156198b69e996&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2422182159","pubTimestamp":1711547559,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"挖贝网3月27日，太龙药业 近日发布2023年年度报告，报告期内公司实现营业收入2,069,908,736.55元，同比增长5.57%；归属于上市公司股东的净利润43,556,724.78元，较上年同期扭亏为盈。报告期内经营活动产生的现金流量净额为43,737,575.40元，归属于上市公司股东的净资产1,578,493,578.60元。公告显示，报告期内董事、监事、高级管理人员报酬合计633.05万元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600222":"太龙药业","BK0239":"医药制造","BK0188":"融资融券"},"translate_title":"Tailong Pharmaceutical's net profit in 2023 was 43.5567 million, turning losses into profits year-on-year. General Manager Li Jingliang's salary was 1.1705 million","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600222":0.9},"content_text":"挖贝网3月27日，太龙药业 近日发布2023年年度报告，报告期内公司实现营业收入2,069,908,736.55元，同比增长5.57%；归属于上市公司股东的净利润43,556,724.78元，较上年同期扭亏为盈。报告期内经营活动产生的现金流量净额为43,737,575.40元，归属于上市公司股东的净资产1,578,493,578.60元。报告期内，随着外部环境的稳定，公司经营业务稳健增长、持续向好，营业收入同比增长5.57%，特别是公司中药口服液业务通过加强市场拓展、丰富产品矩阵、优化产品结构，营业收入实现了26.47%的增长；同时，持续强化各经营板块成本管控,推进降本增效举措,带动公司整体毛利及净利润实现大幅增长。公告显示，报告期内董事、监事、高级管理人员报酬合计633.05万元。董事长尹辉未在公司领取报酬，副董事长、总经理李景亮从公司获得的税前报酬总额117.05万元，常务副总经理、财务负责人赵海林从公司获得的税前报酬总额90.07万元，副总经理、董秘李念云从公司获得的税前报酬总额39.29万元。公告披露显示董事会决议通过的本报告期利润分配预案或公积金转增股本预案：综合考虑公司经营情况及未来长期发展的资金需求等因素，公司2023年度拟不分配现金股利，亦不实施包括资本公积转增股本在内的其他形式的分配。报告期内，公司采用集中竞价方式实施股份回购金额4,206.78万元，根据相关法律法规的规定，公司已实施的股份回购金额视同现金分红金额，纳入本年度现金分红的相关比例计算，按此计算，2023年度公司现金红利总额占2023年度归属于母公司股东的净利润比例为96.58%。该预案已经公司董事会、监事会审议通过，并将提交公司股东大会审议。挖贝网资料显示，太龙药业主要业务为药品制造和药品研发服务，具体包含药品制剂、中药饮片、药品研发服务和药品药材流通四个板块的业务。","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2422182159"}

太龙药业2023年净利4355.67万同比扭亏为盈 总经理李景亮薪酬117.05万

精彩评论

太龙药业2023年净利4355.67万同比扭亏为盈总经理李景亮薪酬117.05万